case_images: PMC10876893_01
case_images: Symptom and treatment.
case_images: fimmu-15-1321236-g001.jpg
case_images: PMC10876893_01_fimmu-15-1321236-g001.jpg
case_images: f1
case_images: Moxifloxacin and piperacillin-tazobactam were ceased, and voriconazole (200 mg q12h) was added by December 22, 2022, given her history of aspergillus and high risk of aspergillus re-infection, and we reduced methylprednisolone as well (40 mg qd) ( Figure 1 ).
case_images: Characteristics of CT graphs.
case_images: fimmu-15-1321236-g002.jpg
case_images: PMC10876893_01_fimmu-15-1321236-g002.jpg
case_images: f2
case_images: COVID-19 RNA test was positive. Chest computerized tomography suggested new bilateral interstitial pneumonia ( Figure 2 ).
case_images: Laboratory Inspection. (A) Blood routine test and proportion of different blood cells. NEU: neutrophil, LYM: lymphocyte. (B) Lymphocyte subgroup analysis. (C) PCT: Procalcitonin. (D) DDi: D-Dimer. (E) BNP: B-type natriuretic peptide.
case_images: fimmu-15-1321236-g003.jpg
case_images: PMC10876893_01_fimmu-15-1321236-g003.jpg
case_images: f3
case_images: Serum interleukin-6 (IL-6) was 34.17 pg/mL ( Figure 3 ), which was believed to be relative to severe COVID-19.